Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$211,125
+$28,651 QoQ
Shares Held
839
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#3,931
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fairscale Capital, LLC holds $3,064,115 across 11 Drug Manufacturers - General names. ABBV ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,779 | $959,752 | |
| 2 | LLY |
ELI LILLY & Co
|
596 | $714,860 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,863 | $624,895 | |
| 4 | NVS |
Novartis AG
|
1,681 | $263,446 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
839 | $211,125 | |
| 6 | AMGN |
Amgen Inc
|
310 | $112,257 | |
| 7 | PFE |
Pfizer Inc
|
3,280 | $78,982 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,197 | $68,971 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,125 | 839 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $182,474 | 839 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $191,703 | 839 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $143,786 | 621 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $115,270 | 621 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $99,312 | 474 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $90,271 | 508 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $100,319 | 508 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $87,132 | 508 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||